H.R. 890: Stopping Pharma’s Ripoffs and Drug Savings For All Act

H.R. 890 is a federal bill in the 119th Congress. Currently, drug companies can list multiple patents as covering a single drug. This bill changes that by requiring a drug patent owner to prove that each additional patent listed for a drug covers a distinct invention. If they cannot prove this, then… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.